Amarin Corp Plc (AMRN)

[ramfan60]

From thomas on the YMB

Cantor Fitzgerald analyst Louise Chen noted that the EU's CHMP published its agenda for meetings taking place this week, which includes reference to icosapent ethyl. The meeting timing puts Amarin in-line to "on the earlier side" of potentially receiving a CHMP opinion that it has said would occur in late January to early February of this year, according to Chen, who expects a positive CHMP opinion and for EMA approval to follow within 67 days of a CHMP decision. Chen, who thinks recent updates highlight the "underappreciated opportunities" for Vascepa outside of the U.S., keeps an Overweight rating on Amarin shares with a $10 price target.